Nurix Therapeutics, Inc. NRIX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s accounts payable?
- Nurix Therapeutics, Inc. (NRIX) reported accounts payable of $10.29M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s accounts payable changed year-over-year?
- Nurix Therapeutics, Inc.'s accounts payable increased by 22.6% year-over-year, from $8.4M to $10.29M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s accounts payable has grown at a 26.9% compound annual growth rate (CAGR), from $3.41M to $11.22M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.